Global Stem

Global Stem Cells Group is a regenerative medicine company focused on stem cell research, clinical applications, physician education, and commercialization of regenerative medicine products and services. The company operates as a multi-division group that supports doctors and clinics with training, protocols, equipment, biologics, and turnkey stem cell center solutions. Its activities span point-of-care regenerative medicine, exosome and peptide product lines, and affiliated treatment centers and educational programs under brands such as ISSCA and CELLGENIC. The business appears to be more commercial-services and platform-oriented than a traditional therapeutics developer with a disclosed human drug pipeline. It has reported an international footprint across more than 40 countries and has expanded facilities and partnerships in markets including Mexico, Brazil, Indonesia, Dubai, Pakistan, and the Dominican Republic.